Eflornithine
Back to searchMolecule Structure
Scientific Name
Eflornithine
Description of the Drug
Eflornithine is a medication used topically to reduce unwanted facial hair growth in women. The postulated mechanism of action is through irreversible inhibition of ornithine decarboxylase (ODC) in the skin.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06243
http://www.drugbank.ca/drugs/DB06243
Brand Name(s)
Not Available
Company Owner(s)
Skinmedica Inc, Sanofi Aventis Us Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Ornithine decarboxylase | SINGLE PROTEIN | INHIBITOR | CHEMBL1869 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL26327 | ||||||
Human Metabolome Database | HMDB0242197 | ||||||
DrugBank | DB06243 | ||||||
PubChem: Thomson Pharma | 15195195 | ||||||
PubChem | 3009 | ||||||
Mcule | MCULE-9516392560 | ||||||
LINCS | LSM-45424 | ||||||
Nikkaji | J65.668B | ||||||
BindingDB | 50028197 | ||||||
EPA CompTox Dashboard | DTXSID3020467 | ||||||
DrugCentral | 990 | ||||||
Brenda | 217268 | 13680 | 156333 | 160279 | 3677 | 1672 | 118312 |
Guide to Pharmacology | 5176 | ||||||
rxnorm | VANIQA | EFLORNITHINE HYDROCHLORIDE | EFLORNITHINE | ||||
KEGG Ligand | C07997 | ||||||
ChEBI | 41948 |